Study of A Combination Pill With GS-7977 and GS-5885 for Hepatitis C in People With HIV
NCT01878799
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
50
Enrollment
NIH
Sponsor class
Conditions
Hepatitis C
HIV
Interventions
DRUG:
GS-7977/GS- 5885 FDC
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)